Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2002-07-29
Original market date: See footnote 1
1992-12-31
Product name:
M.V.I. 12
DIN:
01927841 Electronic product monograph is not available
Company:
AVENTIS PHARMA INC
2905 Place Louis-R. Renaud
Laval
Quebec
Canada
H7V 0A3
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Intravenous
Number of active ingredient(s):
12
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
88:28.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05XC VITAMINS
Active ingredient group (AIG) number:See footnote5
1242401001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| ASCORBIC ACID | 20 MG / ML |
| BIOTIN | 12 MCG / VIAL |
| D-PANTOTHENIC ACID (PANTHENOL) | 3 MG / VIAL |
| FOLIC ACID | 0.08 MG / VIAL |
| NICOTINAMIDE | 8 MG / VIAL |
| PYRIDOXINE HYDROCHLORIDE | 0.8 MG / VIAL |
| VITAMIN A | 660 UNIT / ML |
| VITAMIN B1 (THIAMINE HYDROCHLORIDE) | 0.6 MG / ML |
| VITAMIN B12 | 1 MCG / VIAL |
| VITAMIN B2 (RIBOFLAVIN 5'-PHOSPHATE SODIUM) | 0.72 MG / ML |
| VITAMIN D | 40 UNIT / ML |
| VITAMIN E (DL-ALPHA TOCOPHERYL ACETATE) | 2 UNIT / VIAL |